Hotline:
+ 49 (0) 2204 2918806

Market studies for category X

Items 1 to 10 of 14 total

  1. Net price*
    Year
  2. $250.00
    2014
    Für diese Studie liegt keine Bewertung vor.

    Xoft Inc. - Medical Equipment - Deals and Alliances Profile

    GlobalData
    24 Pages
    Xoft Inc. (Xoft) is a medical device company. The company develops brachytherapy systems using its miniaturized X-ray tube technology to apply a therapeutic dose of isotope-free radiation to a tumor target. Its products include axxent controller, HDR X-ray source, axxent applicators and other axxent accessories such as physics kit, rigid
    Englisch | Zukunftsanalyse | SKU: 159281
  3. $250.00
    2014
    Für diese Studie liegt keine Bewertung vor.

    Xcellerex, Inc. - Pharmaceuticals & Healthcare - Deals and Alliances Profile

    GlobalData
    23 pages
    Xcellerex, Inc. (Xcellerex) is a biotechnology company. The company develops biomolecule manufacturing technologies and platforms. Its products include flexfactory biomanufacturing platform, XDR single-use bioreactors, XDM QUAD single-use mixing systems and XDA disposable assemblies. Xcellerex provides services such as process development
    Englisch | Zukunftsanalyse | SKU: 331889
  4. $250.00
    2014
    Für diese Studie liegt keine Bewertung vor.

    X-GEN Pharmaceuticals, Inc. - Pharmaceuticals & Healthcare - Deals and Alliances Profile

    GlobalData
    16 pages
    X-GEN Pharmaceuticals, Inc. (X-GEN) is a pharmaceutical company. The company develops, manufactures, and delivers generic pharmaceuticals. Its products include inhalants: ammonia inhalant (non-rx), amyl nitrate inhalant usp (rx), injectables: acetazolamide for inj. usp, amphotericin b for inj. usp, bacitracin for inj. usp, colistimethate
    Englisch | Zukunftsanalyse | SKU: 338876
  5. $250.00
    2014
    Für diese Studie liegt keine Bewertung vor.

    Xceed Molecular - Medical Equipment - Deals and Alliances Profile

    GlobalData
    15 pages
    Xceed Molecular (Xceed) is a molecular diagnostic company, engaged in the design, development and distribution of diagnostic test kits, reagents and instruments for the in-vitro diagnostic markets. In addition, the company offers services such as processing samples and analysis for genetic tests. The company's product line includes custom
    Englisch | Zukunftsanalyse | SKU: 270014
  6. $250.00
    2014
    Für diese Studie liegt keine Bewertung vor.

    Xcelience, LLC - Pharmaceuticals & Healthcare - Deals and Alliances Profile

    GlobalData
    17 pages
    Xcelience, LLC (Xcelience) is a pharmaceutical company. The company provides formulation development and manufacturing solutions. Its services include formulation development, preformulation, analytical method development, validation and stability, GMP manufacturing, packaging and labeling, clinical packaging and chemistry playbook. The c
    Englisch | Zukunftsanalyse | SKU: 331911
  7. $250.00
    2014
    Für diese Studie liegt keine Bewertung vor.

    Xceleron Inc - Pharmaceuticals & Healthcare - Deals and Alliances Profile

    GlobalData
    16 pages
    Xceleron Inc (Xceleron) is a pharmaceutical service provider. The company provides analytical solutions for drug development programs. It uses accelerator mass spectrometry (AMS) technology delivers solutions. The company provides services such as pharmaceutical and biobased services. Xceleron’s technology support preclinical analysis f
    Englisch | Zukunftsanalyse | SKU: 359780
  8. $250.00
    2014
    Für diese Studie liegt keine Bewertung vor.

    Xenetic Biosciences plc (XEN) - Pharmaceuticals & Healthcare - Deals and Alliances Profile

    GlobalData
    55 pages
    Xenetic Biosciences plc (Xenetic) is a bio-pharmaceutical company. It carries out the development of drugs for cancer therapies and vaccines. The company has developed proprietary patented technologies to create a new generation drug and vaccine products such as PolyXen for protein drug delivery, ImuXen for vaccine delivery and Oncohist.
    Englisch | Zukunftsanalyse | SKU: 163506
  9. $250.00
    2014
    Für diese Studie liegt keine Bewertung vor.

    XERIS Pharmaceuticals, Inc. - Pharmaceuticals & Healthcare - Deals and Alliances Profile

    GlobalData
    17 pages
    XERIS Pharmaceuticals, Inc. (XERIS) is a biopharmaceutical company. The company develops injectables for the treatment of diabetes, epilepsy, and immunology. Its products include xerisol glucagon and xeriject diazepam. XERIS’s proprietary delivery system offers several advantages over existing needle and needle-free formulations which i
    Englisch | Zukunftsanalyse | SKU: 331904
  10. $250.00
    2014
    Für diese Studie liegt keine Bewertung vor.

    Xention Limited - Pharmaceuticals & Healthcare - Deals and Alliances Profile

    GlobalData
    18 pages
    Xention Limited (Xention) formerly Xention Discovery Ltd. is a biopharmaceutical company. The company discovers and develops ion channel-modulating drugs. Its products include XEN-D0103 and ikach. Xention uses its technology to develop a portfolio of drug candidates in the area of atrial fibrillation. The company product includes drug can
    Englisch | Zukunftsanalyse | SKU: 338881
  11. $250.00
    2014
    Für diese Studie liegt keine Bewertung vor.

    Xanodyne Pharmaceuticals, Inc. - Pharmaceuticals & Healthcare - Deals and Alliances Profile

    GlobalData
    24 pages
    Xanodyne Pharmaceuticals, Inc. (Xanodyne) is a pharmaceutical company. It undertakes the development, production and commercialization of pain management and women's healthcare products. Its products include roxicodone, XP12B and XP20B. Xanodyne also develops product candidates through the application of proprietary drug delivery and form
    Englisch | Zukunftsanalyse | SKU: 331879

Items 1 to 10 of 14 total